Russia's Covid-19 vaccine showed antibody response in initial trials


Modified 5 Sep 2020, 3:12 am

COVID-19 | Russia’s "Sputnik-V" Covid-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.

The results of the two trials, conducted in June-July this year involving 76 participants, showed 100 percent of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In